Page 8 - Amitabh Chandra News Today : Breaking News, Live Updates & Top Stories | Vimarsana
When the price isn t right
politico.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from politico.com Daily Mail and Mail on Sunday newspapers.
What Will It Take to Pandemic-Proof America?
newyorker.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newyorker.com Daily Mail and Mail on Sunday newspapers.
Analysis Group Welcomes New Affiliates and Announces Senior-Level Promotions
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
A Shot in the Arm
Vaccines are underfunded, understudied, and underappreciated as a vital tool in public health. Could COVID-19 be the start of a vaccine renaissance?
Maurice Hilleman woke suddenly. It was near 1 a.m. on March 23, 1963, when his 5-year-old daughter, Jeryl Lynn, tottered into the bedroom and announced that she was feeling unwell. Her throat was swollen, and she was hot with a fever. Hilleman, an esteemed microbiologist who, over the course of his career, would develop more than 40 vaccines that would save millions of lives made an educated guess that she was sick with mumps. As a father, he saw a sick daughter he wanted to help. As a scientist, he saw an opportunity he didn’t want to miss. He got out of bed, jumped in his car, and cruised off in the middle of the night to his laboratory in the Philadelphia offices of the pharmaceutical company Merck. A little while later, he returned home with a few cotton swabs and a vial of chicken broth. He woke Jeryl Lynn,
To embed, copy and paste the code into your website or blog:
Johnson & Johnson and the “big three” distributors of prescription drugs McKesson, AmerisourceBergen and Cardinal Health have disclosed that they will take tax deductions on sums they will fork over to states, local governments, Indian tribes, and others that sued them over damages that they say occurred after they flooded the country with powerful painkillers, the Washington Post reported.
The four companies have agreed to pay between $5 billion and $8 billion each to reimburse communities for the costs they suffered in dealing with millions of deaths, addictions, and debilitations caused by opioids, their synthetic versions, and illicit drugs they opened the door to.